Skyline Medical Inc. (SKLN) 0.1245 $SKLN
SOK Partners LLC Entered Into a Share Purchase Agreement With Prospect Park Capital Corp.
Marketwire - Tue Sep 09, 10:52AM CDT
SOK Partners LLC ("SOK"
announced that it has entered into a share purchase agreement (the "Agreement" with Prospect Park Capital Corp. (TSX VENTURE: PPK.P) (the "Corporation" . Pursuant to the Agreement, the Corporation has agreed to acquire (such acquisition, the "Skyline Investment" $1,700,000 of common shares of Skyline Medical Inc. from SOK for the purchase price of $1,000,000. The purchase price of $1,000,000 shall be payable as follows: (i) $400,000 payable at the closing of the Skyline Investment (the "Closing" ; (ii) $300,000 payable at the Closing by the issuance of 1,304,347 common shares of the Corporation ("Shares" at a deemed price of $0.23 per share; and (iii) $300,000 payable within six (6) months of the Closing by the issuance of 1,714,285 Shares at a deemed price of $0.175 per share (the "Subsequent Share Issuance" .
Prospect Park Capital Corp. Enters Into Definitive Agreements and Files Management Information Circular on SEDAR in Connection With Proposed Qualifying Transaction
Marketwire - Wed Sep 03, 3:45PM CDT
Prospect Park Capital Corp. ("Prospect Park" (TSX VENTURE: PPK.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the "Exchange" , is pleased to provide this update on the proposed respective transactions with SOK Partners LLC ("SOK" and IOI, LLC ("IOI" that were previously announced on October 7, 2013. Pursuant to the terms of a share purchase agreement dated August 28, 2014 between Prospect Park and SOK (the "SOK Agreement" for the acquisition of common shares ("Skyline Shares" of Skyline Medical Inc. ("Skyline" (such acquisition, the "Skyline Investment" and pursuant to the terms of a subscription agreement between Prospect Park and IOI (the "IOI Agreement" for the subscription of units of IOI (the "IOI Investment" , subject to completion of certain conditions precedent, including, receipt of all necessary regulatory and Exchange approvals, the Skyline Investment and the IOI Investment (together, the "Transactions" will collectively constitute Prospect Park's "Qualifying Transaction" as defined by Policy 2.4 of the Exchange.
IPOs and Transactions: August 25 - 29
PR Newswire - Tue Sep 02, 12:57PM CDT
Vintage, the regulatory compliance and shareholder communications division of PR Newswire, has released its weekly IPO and Transaction summary.
Skyline Medical Lands Large Healthcare Systems in California, Wisconsin and New York
ACCESSWIRE - Tue Aug 26, 5:46AM CDT
Skyline Medical Continues to Penetrate Strategic Geographic Markets by Converting Product Evaluations into Sales of Their STREAMWAY(R) Fluid Waste Management System
Skyline Medical Inc. Announces Second Quarter 2014 Results
ACCESSWIRE - Fri Aug 08, 5:16AM CDT
17 STREAMWAY(r) units sold; 17 trials in progress or scheduled for 2014
Skyline Medical Announces Private Placement of Senior Convertible Notes and Warrants
ACCESSWIRE - Thu Jul 24, 8:25AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / July 24, 2014 / Skyline Medical Inc. (OTCQB: SKLN) (the "Company" today announced the sale, in a private placement, of a senior convertible note, in the original principal amount of $610,978 (the "Investor Note" , due on July 23, 2015, and a warrant (the "Investor Warrant" to initially acquire up to 2,036,593 shares of the Company's common stock (the "Investor Warrant Shares" . The Investor Warrant is exercisable at an exercise price of $0.165 per share and expires on July 23, 2019. The purchase price for the Investor Note and Investor Warrant was $500,000.
Skyline Medical Announces Two New Trials of the STREAMWAY(R) System
Marketwire - Wed Jun 18, 9:45AM CDT
Skyline Medical Inc. (OTCQB: SKLN) today announced that two new trials of the STREAMWAY Fluid Waste Management System are underway in North Carolina and California. Brier Creek Ambulatory Surgery Center, affiliated with the Duke Health Care System, and located in Raleigh, North Carolina, is in the process of validating the STREAMWAY Fluid Management System for endoscopic procedures. Additionally, Beverly Hospital, affiliated with the Adventist Health System, and located in Montebello, California, is conducting a trial in its radiology department.
Skyline Medical Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 7:00AM CDT
Skyline Medical Inc. (OTCQB: SKLN) -- producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal -- today reported its results for the full year ended December 31, 2013.
Multiple Insiders of Skyline Medical Inc. (SKLN)-Other O bought Shares of SKLN
M2 - Fri Mar 21, 7:39AM CDT
Reported by InsiderCow.com at 2014-03-20 10:36:27 ET
Skyline Medical to Demonstrate Revolutionary Technology at Association of periOperative Registered Nurses Conference
PR Newswire - Tue Mar 18, 7:30AM CDT
Skyline Medical (OTCQB: SKLN) will exhibit its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo in late March in Chicago.
Skyline Medical to Penetrate Important Northeast Region Through Exclusive Distribution Agreement with O.R. Specialties
PR Newswire - Thu Mar 13, 7:30AM CDT
To expand the reach of its FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal in the influential northeast region of the United States, Skyline Medical (OTCQB: SKLN) recently signed a distribution agreement with O.R. Specialties.
Skyline Medical Expands Sales Force to Meet Growing Demand
PR Newswire - Mon Feb 24, 7:30AM CST
Skyline Medical (OTCQB: SKLN) has assembled a dynamic team of sales leaders to build out a larger U.S. sales force in response to increasing demand for its STREAMWAY System -- a revolutionary, FDA-approved system for automated, direct-to-drain medical fluid disposal.
Skyline Medical Announces $2.06 Million Private Placement Transaction
PR Newswire - Wed Feb 05, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company" , producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that it has entered into a definitive agreement with investors, including Skyline Medical CEO Josh Kornberg, to sell in a private placement an aggregate 20,550 shares of Series A Convertible Preferred stock and warrants. The transaction was conducted without an underwriter or placement agent and resulted in gross proceeds to the Company of $2.06 million, before deducting offering expenses. The warrants are exercisable at an exercise price of $0.325 per share, which represents a purchase price of 125% per initial conversion price, and expire 5 years from the closing date. The convertible preferred stock will pay a 6% dividend annually and is convertible at a conversion price of $0.26 per share, subject to adjustment in certain circumstances.
Skyline Medical Expands Early Access to Its Revolutionary Fluid Waste Management System Through Attainia Partnership
PR Newswire - Thu Jan 30, 7:00AM CST
Skyline Medical (OTCQB: SKLN) is making it easier for hospitals and surgery centers to include state-of-the-art waste management systems in new and renovated facilities. The company is making its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal available through Attainia software -- the world's most widely used healthcare equipment planning and budgeting software.
SOK Partners LLC Entered Into a Share Purchase Agreement With Prospect Park Capital Corp.
Marketwire - Tue Sep 09, 10:52AM CDT
SOK Partners LLC ("SOK"
announced that it has entered into a share purchase agreement (the "Agreement" with Prospect Park Capital Corp. (TSX VENTURE: PPK.P) (the "Corporation" . Pursuant to the Agreement, the Corporation has agreed to acquire (such acquisition, the "Skyline Investment" $1,700,000 of common shares of Skyline Medical Inc. from SOK for the purchase price of $1,000,000. The purchase price of $1,000,000 shall be payable as follows: (i) $400,000 payable at the closing of the Skyline Investment (the "Closing" ; (ii) $300,000 payable at the Closing by the issuance of 1,304,347 common shares of the Corporation ("Shares" at a deemed price of $0.23 per share; and (iii) $300,000 payable within six (6) months of the Closing by the issuance of 1,714,285 Shares at a deemed price of $0.175 per share (the "Subsequent Share Issuance" . Prospect Park Capital Corp. Enters Into Definitive Agreements and Files Management Information Circular on SEDAR in Connection With Proposed Qualifying Transaction
Marketwire - Wed Sep 03, 3:45PM CDT
Prospect Park Capital Corp. ("Prospect Park"
(TSX VENTURE: PPK.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the "Exchange" , is pleased to provide this update on the proposed respective transactions with SOK Partners LLC ("SOK" and IOI, LLC ("IOI" that were previously announced on October 7, 2013. Pursuant to the terms of a share purchase agreement dated August 28, 2014 between Prospect Park and SOK (the "SOK Agreement" for the acquisition of common shares ("Skyline Shares" of Skyline Medical Inc. ("Skyline" (such acquisition, the "Skyline Investment" and pursuant to the terms of a subscription agreement between Prospect Park and IOI (the "IOI Agreement" for the subscription of units of IOI (the "IOI Investment" , subject to completion of certain conditions precedent, including, receipt of all necessary regulatory and Exchange approvals, the Skyline Investment and the IOI Investment (together, the "Transactions" will collectively constitute Prospect Park's "Qualifying Transaction" as defined by Policy 2.4 of the Exchange. IPOs and Transactions: August 25 - 29
PR Newswire - Tue Sep 02, 12:57PM CDT
Vintage, the regulatory compliance and shareholder communications division of PR Newswire, has released its weekly IPO and Transaction summary.
Skyline Medical Lands Large Healthcare Systems in California, Wisconsin and New York
ACCESSWIRE - Tue Aug 26, 5:46AM CDT
Skyline Medical Continues to Penetrate Strategic Geographic Markets by Converting Product Evaluations into Sales of Their STREAMWAY(R) Fluid Waste Management System
Skyline Medical Inc. Announces Second Quarter 2014 Results
ACCESSWIRE - Fri Aug 08, 5:16AM CDT
17 STREAMWAY(r) units sold; 17 trials in progress or scheduled for 2014
Skyline Medical Announces Private Placement of Senior Convertible Notes and Warrants
ACCESSWIRE - Thu Jul 24, 8:25AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / July 24, 2014 / Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
today announced the sale, in a private placement, of a senior convertible note, in the original principal amount of $610,978 (the "Investor Note" , due on July 23, 2015, and a warrant (the "Investor Warrant" to initially acquire up to 2,036,593 shares of the Company's common stock (the "Investor Warrant Shares" . The Investor Warrant is exercisable at an exercise price of $0.165 per share and expires on July 23, 2019. The purchase price for the Investor Note and Investor Warrant was $500,000. Skyline Medical Announces Two New Trials of the STREAMWAY(R) System
Marketwire - Wed Jun 18, 9:45AM CDT
Skyline Medical Inc. (OTCQB: SKLN) today announced that two new trials of the STREAMWAY Fluid Waste Management System are underway in North Carolina and California. Brier Creek Ambulatory Surgery Center, affiliated with the Duke Health Care System, and located in Raleigh, North Carolina, is in the process of validating the STREAMWAY Fluid Management System for endoscopic procedures. Additionally, Beverly Hospital, affiliated with the Adventist Health System, and located in Montebello, California, is conducting a trial in its radiology department.
Skyline Medical Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 7:00AM CDT
Skyline Medical Inc. (OTCQB: SKLN) -- producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal -- today reported its results for the full year ended December 31, 2013.
Multiple Insiders of Skyline Medical Inc. (SKLN)-Other O bought Shares of SKLN
M2 - Fri Mar 21, 7:39AM CDT
Reported by InsiderCow.com at 2014-03-20 10:36:27 ET
Skyline Medical to Demonstrate Revolutionary Technology at Association of periOperative Registered Nurses Conference
PR Newswire - Tue Mar 18, 7:30AM CDT
Skyline Medical (OTCQB: SKLN) will exhibit its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo in late March in Chicago.
Skyline Medical to Penetrate Important Northeast Region Through Exclusive Distribution Agreement with O.R. Specialties
PR Newswire - Thu Mar 13, 7:30AM CDT
To expand the reach of its FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal in the influential northeast region of the United States, Skyline Medical (OTCQB: SKLN) recently signed a distribution agreement with O.R. Specialties.
Skyline Medical Expands Sales Force to Meet Growing Demand
PR Newswire - Mon Feb 24, 7:30AM CST
Skyline Medical (OTCQB: SKLN) has assembled a dynamic team of sales leaders to build out a larger U.S. sales force in response to increasing demand for its STREAMWAY System -- a revolutionary, FDA-approved system for automated, direct-to-drain medical fluid disposal.
Skyline Medical Announces $2.06 Million Private Placement Transaction
PR Newswire - Wed Feb 05, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that it has entered into a definitive agreement with investors, including Skyline Medical CEO Josh Kornberg, to sell in a private placement an aggregate 20,550 shares of Series A Convertible Preferred stock and warrants. The transaction was conducted without an underwriter or placement agent and resulted in gross proceeds to the Company of $2.06 million, before deducting offering expenses. The warrants are exercisable at an exercise price of $0.325 per share, which represents a purchase price of 125% per initial conversion price, and expire 5 years from the closing date. The convertible preferred stock will pay a 6% dividend annually and is convertible at a conversion price of $0.26 per share, subject to adjustment in certain circumstances. Skyline Medical Expands Early Access to Its Revolutionary Fluid Waste Management System Through Attainia Partnership
PR Newswire - Thu Jan 30, 7:00AM CST
Skyline Medical (OTCQB: SKLN) is making it easier for hospitals and surgery centers to include state-of-the-art waste management systems in new and renovated facilities. The company is making its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal available through Attainia software -- the world's most widely used healthcare equipment planning and budgeting software.
